Filter Results:
(5,669)
Show Results For
- All HBS Web
(5,669)
- People (19)
- News (2,280)
- Research (2,569)
- Events (2)
- Multimedia (224)
- Faculty Publications (1,935)
Show Results For
- All HBS Web
(5,669)
- People (19)
- News (2,280)
- Research (2,569)
- Events (2)
- Multimedia (224)
- Faculty Publications (1,935)
- 12 Oct 2015
- News
Google Ventures: Big-time Consumer Health Is Still a Dream
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078]. View Details
- August 2014
- Article
Religion, Politician Identity and Development Outcomes: Evidence from India
By: Sonia Bhalotra, Irma Clots-Figueras, Guilhem Cassan and Lakshmi Iyer
This paper investigates whether the religious identity of state legislators in India influences development outcomes, both for citizens of their religious group and for the population as a whole. Using an instrumental variables approach derived from a regression... View Details
Keywords: Politician Identity; Infant Mortality; Primary Education; India; Muslim; Fairness; Religion; Government and Politics; India
Bhalotra, Sonia, Irma Clots-Figueras, Guilhem Cassan, and Lakshmi Iyer. "Religion, Politician Identity and Development Outcomes: Evidence from India." Journal of Economic Behavior & Organization 104 (August 2014): 4–17.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- Article
Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected
By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny
Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,... View Details
Keywords: Health Care Providers; Hospitals; Insurance Market Regulation; Price Regulation; Markets; Health Care and Treatment; Cost; Quality; Insurance; Price; Governing Rules, Regulations, and Reforms
Pany, Maximilian J., Michael E. Chernew, and Leemore S. Dafny. "Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected." Health Affairs 40, no. 9 (September 2021): 1386–1394.
- June 2021
- Teaching Note
Michael Phelps: 'It's Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
Teaching Note for HBS Case No. 421-044. In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the... View Details
- February 2014
- Teaching Note
Community Health Workers in Zambia: Incentive Design and Management
By: Nava Ashraf and Kristin Johnson
Keywords: Developing Countries and Economies; Training; Health Care and Treatment; Compensation and Benefits; Recruitment; Selection and Staffing; Mission and Purpose; Non-Governmental Organizations; Motivation and Incentives; Health Industry; Zambia
Ashraf, Nava, and Kristin Johnson. "Community Health Workers in Zambia: Incentive Design and Management." Harvard Business School Teaching Note 914-024, February 2014. (Request a courtesy copy.)
- 16 May 2017
- Blog Post
Making the Move into Digital Health and Software Engineering
We caught up with Andrea Coravos (HBS 2017) after a Q&A she did with the MBA Voices blog during her second year at HBS. Coravos reflects on her time at HBS and how she transitioned into digital health and engineering following a... View Details
- 26 Feb 2025
- Blog Post
Exploring value-based care: My summer internship with Main Street Health
The summer between my first and second year at HBS I had the opportunity to intern at Main Street Health, a Nashville-based startup focused on facilitating value-based care for rural Medicare populations. Main Street View Details
Keywords: Health Care
- 23 Apr 2014
- News
Are Electronic Cigarettes a Public Good or Health Hazard?
- January 2019
- Teaching Note
Pricing PatientPing
By: Frank V. Cespedes
Teaching Note for HBS No. 818-017. PatientPing sells a software platform that allows health care providers to receive real-time notifications (“pings”) when one of their patients is admitted to or discharged from a health-care facility. The platform facilitates... View Details
- 07 Jan 2025
- Blog Post
Revolutionizing Wellness: Kate Twist (MBA 2008) Shapes the Future of Consumer Health Brands
exists at the intersection of the healthcare and beauty industries, educating consumers on the modern way to take care of their skin. It's designed to be a more inviting and accessible experience for... View Details
- 01 Sep 2007
- News
‘Redefining Health Care’: Medical Homes or Archipelagos to Navigate?
- 07 Feb 2007
- News
A Failing Transparency of Design Principles in Health Care?
- September 2023
- Teaching Note
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation. View Details
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional... View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- 2012
- Report
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
By: Mark R. Kramer, Kyle Peterson, Matthew Rehrig, Mike Stamp and Samuel Kim
Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems. View Details
Keywords: Shared Value; Low- And Middle-income Economies; Health Care and Treatment; Global Range; Pharmaceutical Industry; Medical Devices and Supplies Industry
Kramer, Mark R., Kyle Peterson, Matthew Rehrig, Mike Stamp, and Samuel Kim. "Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health." Report, FSG, 2012.